AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
68.30
+0.34 (0.50%)
Jan 22, 2025, 11:58 AM EST - Market open
AstraZeneca Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 88.8, with a low estimate of 82 and a high estimate of 97. The average target predicts an increase of 30.01% from the current stock price of 68.30.
Analyst Consensus: Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for AstraZeneca stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2024 |
| Erste Group | Erste Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 11, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $95 | Strong Buy | Maintains | $90 → $95 | +39.09% | Aug 12, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +24.45% | May 30, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $97 | Strong Buy | Initiates | $97 | +42.02% | May 30, 2024 |
Financial Forecast
Revenue This Year
54.31B
from 45.81B
Increased by 18.56%
Revenue Next Year
58.35B
from 54.31B
Increased by 7.44%
EPS This Year
4.16
from 3.81
Increased by 9.23%
EPS Next Year
4.80
from 4.16
Increased by 15.25%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 56.7B | 62.6B | 69.1B | |||
| Avg | 54.3B | 58.4B | 61.8B | |||
| Low | 44.9B | 51.9B | 55.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 23.8% | 15.2% | 18.5% | |||
| Avg | 18.6% | 7.4% | 5.9% | |||
| Low | -2.0% | -4.5% | -5.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.45 | 5.58 | 6.59 | |||
| Avg | 4.16 | 4.80 | 5.32 | |||
| Low | 3.31 | 3.61 | 4.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 16.9% | 34.0% | 37.5% | |||
| Avg | 9.2% | 15.3% | 11.0% | |||
| Low | -13.1% | -13.2% | -15.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.